# Forecasting Hypersensitivity Against PEG-asparaginase to Optimize Outcome in ALL

> **NCT06195735** · — · COMPLETED · sponsor: **Aarhus University Hospital** · enrollment: 649 (actual)

## Conditions studied

- Acute Lymphoblastic Leukemia

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06195735
- **Lead sponsor:** Aarhus University Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2020-07-17
- **Primary completion:** 2023-12-21
- **Final completion:** 2023-12-21
- **Target enrollment:** 649 (ACTUAL)
- **Last updated:** 2024-01-08

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06195735

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06195735, "Forecasting Hypersensitivity Against PEG-asparaginase to Optimize Outcome in ALL". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT06195735. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*